EUVIMEDEUVIMED entdecken
Systematische Übersicht

Cigarette smoking and disease activity, organ damage, and cutaneous manifestations in systemic lupus erythematosus: a systematic review

Nermeen A Awad, Lujain B Baghlaf, Rasha A Alsulami, Samah Alotaibi, Sarah K Alshehabi, Wed S Bin Madhi

Annals of Middle Eastern Medicine · 18.08.2026 · 2 (3) · 281-289

DOI: 10.24911/amem.15-2868 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Annals of Middle Eastern Medicine, online erschienen am 15.08.2026. Verfasst von Nermeen A Awad und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Smoking may modify systemic lupus erythematosus (SLE) activity, damage, and phenotype. This review aims to summarize associations between smoking exposure and SLE outcomes.

Methods

Systematic review of primary studies assessing smoking in SLE and reporting clinical or biomarker outcomes. Five eligible studies (2002–2021) were included (total N=1,079). Participants were predominantly female (87–96.2%); where reported, most were Caucasian (73.7–92%) with mean/median age 37–49 years and disease duration ~9–13.5 years. Smoking exposure definitions varied substantially, limiting direct quantitative pooling and precluding meta-analysis across studies.

Results

Ever-smoking prevalence ranged ~37–51%. In one observational study, current smokers had higher disease activity than never smokers (mean total SLEDAI 15.63±1.63 vs 9.03±0.99; p=0.0024) and a dose–response by packs/day (p=0.001). In a retrospective cohort, never exposure to active or second-hand smoke reduced risk of damage accrual (SDI>0: RR 0.78, 95% CI 0.62–0.97; p=0.0228). Heavy smoking (>20 pack-years) was associated with discoid rash (OR 2.22), photosensitivity (OR 2.19) and neurological disorder (OR 3.16), but inversely associated with renal disorder (OR 0.40), non-erosive arthritis (OR 0.45) and haematological disorder (OR 0.40). Current smoking increased cutaneous damage (any OR 2.73; scarring OR 4.70; active rash OR 6.18). IL-17A levels were similar in SLE and controls, did not correlate with SLEDAI-2K or SDI, and inversely correlated with years of smoking (Rs≈−0.43; p≈0.001). Another study reported no significant differences in cumulative damage scores across smoking categories.

Conclusion

Evidence from five heterogeneous studies links smoking with higher SLE activity and cutaneous damage and suggests phenotype-specific associations. Standardized exposure measures and prospective designs are needed. 





 



 

Zitieren

APA

Awad, N. A., Baghlaf, L. B., Alsulami, R. A., Alotaibi, S., Alshehabi, S. K., & Madhi, W. S. B. (2026). Cigarette smoking and disease activity, organ damage, and cutaneous manifestations in systemic lupus erythematosus: a systematic review. Annals of Middle Eastern Medicine, 2(3), 281-289. https://doi.org/10.24911/amem.15-2868

Vancouver

Awad NA, Baghlaf LB, Alsulami RA, Alotaibi S, Alshehabi SK, Madhi WSB. Cigarette smoking and disease activity, organ damage, and cutaneous manifestations in systemic lupus erythematosus: a systematic review. Annals of Middle Eastern Medicine. 2026;2(3):281-289. doi:10.24911/amem.15-2868

BibTeX
@article{Awad2026,
  author = {Awad, Nermeen A and Baghlaf, Lujain B and Alsulami, Rasha A and Alotaibi, Samah and Alshehabi, Sarah K and Madhi, Wed S Bin},
  title = {Cigarette smoking and disease activity, organ damage, and cutaneous manifestations in systemic lupus erythematosus: a systematic review},
  journal = {Annals of Middle Eastern Medicine},
  year = {2026},
  volume = {2},
  number = {3},
  pages = {281--289},
  doi = {10.24911/amem.15-2868}
}
Kostenlos starten →